| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0043 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |